BKV CORPORATION (BKV) Fundamental Analysis & Valuation

NYSE:BKV • US05603J1088

Current stock price

27.63 USD
+0.39 (+1.43%)
At close:
27.86 USD
+0.23 (+0.83%)
After Hours:

This BKV fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. BKV Profitability Analysis

1.1 Basic Checks

  • In the past year BKV was profitable.
  • In the past year BKV had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: BKV reported negative net income in multiple years.
  • BKV had a positive operating cash flow in each of the past 5 years.
BKV Yearly Net Income VS EBIT VS OCF VS FCFBKV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2025 0 100M -100M 200M 300M 400M

1.2 Ratios

  • With a decent Return On Assets value of 5.53%, BKV is doing good in the industry, outperforming 66.03% of the companies in the same industry.
  • BKV has a Return On Equity (8.49%) which is in line with its industry peers.
  • The Return On Invested Capital of BKV (6.33%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA 5.53%
ROE 8.49%
ROIC 6.33%
ROA(3y)1.16%
ROA(5y)1.63%
ROE(3y)2.4%
ROE(5y)3.78%
ROIC(3y)N/A
ROIC(5y)N/A
BKV Yearly ROA, ROE, ROICBKV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2025 0 10 -10 20 -20 30

1.3 Margins

  • BKV has a better Profit Margin (17.09%) than 69.86% of its industry peers.
  • In the last couple of years the Profit Margin of BKV has declined.
  • The Operating Margin of BKV (21.90%) is better than 61.72% of its industry peers.
  • BKV's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 21.9%
PM (TTM) 17.09%
GM N/A
OM growth 3Y-9.77%
OM growth 5YN/A
PM growth 3Y-24.5%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BKV Yearly Profit, Operating, Gross MarginsBKV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2025 0 20 -20

4

2. BKV Health Analysis

2.1 Basic Checks

  • BKV has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • BKV has more shares outstanding than it did 1 year ago.
  • The debt/assets ratio for BKV is higher compared to a year ago.
BKV Yearly Shares OutstandingBKV Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2025 20M 40M 60M 80M
BKV Yearly Total Debt VS Total AssetsBKV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • BKV has an Altman-Z score of 2.41. This is not the best score and indicates that BKV is in the grey zone with still only limited risk for bankruptcy at the moment.
  • BKV has a better Altman-Z score (2.41) than 71.29% of its industry peers.
  • BKV has a Debt/Equity ratio of 0.24. This is a healthy value indicating a solid balance between debt and equity.
  • With a decent Debt to Equity ratio value of 0.24, BKV is doing good in the industry, outperforming 70.33% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Altman-Z 2.41
ROIC/WACC0.75
WACC8.5%
BKV Yearly LT Debt VS Equity VS FCFBKV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

2.3 Liquidity

  • BKV has a Current Ratio of 1.78. This is a normal value and indicates that BKV is financially healthy and should not expect problems in meeting its short term obligations.
  • With a decent Current ratio value of 1.78, BKV is doing good in the industry, outperforming 70.33% of the companies in the same industry.
  • A Quick Ratio of 1.75 indicates that BKV should not have too much problems paying its short term obligations.
  • The Quick ratio of BKV (1.75) is better than 74.16% of its industry peers.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 1.75
BKV Yearly Current Assets VS Current LiabilitesBKV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

6

3. BKV Growth Analysis

3.1 Past

  • BKV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 218.07%, which is quite impressive.
  • Measured over the past years, BKV shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -25.77% on average per year.
  • BKV shows a strong growth in Revenue. In the last year, the Revenue has grown by 77.60%.
  • BKV shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.65% yearly.
EPS 1Y (TTM)218.07%
EPS 3Y-25.77%
EPS 5YN/A
EPS Q2Q%2800%
Revenue 1Y (TTM)77.6%
Revenue growth 3Y-0.65%
Revenue growth 5YN/A
Sales Q2Q%175.57%

3.2 Future

  • BKV is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 32.76% yearly.
  • Based on estimates for the next years, BKV will show a quite strong growth in Revenue. The Revenue will grow by 18.75% on average per year.
EPS Next Y27.91%
EPS Next 2Y24.02%
EPS Next 3Y32.76%
EPS Next 5YN/A
Revenue Next Year58.95%
Revenue Next 2Y33.02%
Revenue Next 3Y18.75%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BKV Yearly Revenue VS EstimatesBKV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
BKV Yearly EPS VS EstimatesBKV Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 0 1 -1 2 3

4

4. BKV Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 17.38 indicates a rather expensive valuation of BKV.
  • BKV's Price/Earnings is on the same level as the industry average.
  • BKV is valuated rather cheaply when we compare the Price/Earnings ratio to 25.60, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 13.59, which indicates a correct valuation of BKV.
  • BKV's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. BKV is cheaper than 74.64% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of BKV to the average of the S&P500 Index (22.84), we can say BKV is valued slightly cheaper.
Industry RankSector Rank
PE 17.38
Fwd PE 13.59
BKV Price Earnings VS Forward Price EarningsBKV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • BKV's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.69
BKV Per share dataBKV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • BKV's earnings are expected to grow with 32.76% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.62
PEG (5Y)N/A
EPS Next 2Y24.02%
EPS Next 3Y32.76%

0

5. BKV Dividend Analysis

5.1 Amount

  • No dividends for BKV!.
Industry RankSector Rank
Dividend Yield 0%

BKV Fundamentals: All Metrics, Ratios and Statistics

BKV CORPORATION

NYSE:BKV (4/2/2026, 8:10:01 PM)

After market: 27.86 +0.23 (+0.83%)

27.63

+0.39 (+1.43%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)02-25
Earnings (Next)05-04
Inst Owners27.19%
Inst Owner Change87.87%
Ins Owners3.59%
Ins Owner Change-10.72%
Market Cap3.02B
Revenue(TTM)1.01B
Net Income(TTM)173.13M
Analysts84.62
Price Target35.09 (27%)
Short Float %12.61%
Short Ratio4.02
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)40.24%
Min EPS beat(2)-6.47%
Max EPS beat(2)86.95%
EPS beat(4)3
Avg EPS beat(4)102.89%
Min EPS beat(4)-6.47%
Max EPS beat(4)165.99%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)25.42%
Min Revenue beat(2)24.8%
Max Revenue beat(2)26.04%
Revenue beat(4)3
Avg Revenue beat(4)8.19%
Min Revenue beat(4)-63.18%
Max Revenue beat(4)45.12%
Revenue beat(8)3
Avg Revenue beat(8)-4.33%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.39%
PT rev (3m)9.95%
EPS NQ rev (1m)-40.51%
EPS NQ rev (3m)-37.86%
EPS NY rev (1m)-5.87%
EPS NY rev (3m)-12.89%
Revenue NQ rev (1m)1.92%
Revenue NQ rev (3m)12.12%
Revenue NY rev (1m)5.74%
Revenue NY rev (3m)12.01%
Valuation
Industry RankSector Rank
PE 17.38
Fwd PE 13.59
P/S 2.98
P/FCF N/A
P/OCF 12.45
P/B 1.48
P/tB 1.5
EV/EBITDA 8.69
EPS(TTM)1.59
EY5.75%
EPS(NY)2.03
Fwd EY7.36%
FCF(TTM)-0.53
FCFYN/A
OCF(TTM)2.22
OCFY8.03%
SpS9.26
BVpS18.64
TBVpS18.47
PEG (NY)0.62
PEG (5Y)N/A
Graham Number25.82
Profitability
Industry RankSector Rank
ROA 5.53%
ROE 8.49%
ROCE 7.62%
ROIC 6.33%
ROICexc 6.8%
ROICexgc 6.85%
OM 21.9%
PM (TTM) 17.09%
GM N/A
FCFM N/A
ROA(3y)1.16%
ROA(5y)1.63%
ROE(3y)2.4%
ROE(5y)3.78%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-19.72%
ROICexgc growth 5YN/A
ROICexc growth 3Y-19.65%
ROICexc growth 5YN/A
OM growth 3Y-9.77%
OM growth 5YN/A
PM growth 3Y-24.5%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Debt/EBITDA 1.28
Cap/Depr 188.84%
Cap/Sales 29.63%
Interest Coverage 13.49
Cash Conversion 63.74%
Profit Quality N/A
Current Ratio 1.78
Quick Ratio 1.75
Altman-Z 2.41
F-Score7
WACC8.5%
ROIC/WACC0.75
Cap/Depr(3y)106.81%
Cap/Depr(5y)118.77%
Cap/Sales(3y)22.32%
Cap/Sales(5y)21.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)218.07%
EPS 3Y-25.77%
EPS 5YN/A
EPS Q2Q%2800%
EPS Next Y27.91%
EPS Next 2Y24.02%
EPS Next 3Y32.76%
EPS Next 5YN/A
Revenue 1Y (TTM)77.6%
Revenue growth 3Y-0.65%
Revenue growth 5YN/A
Sales Q2Q%175.57%
Revenue Next Year58.95%
Revenue Next 2Y33.02%
Revenue Next 3Y18.75%
Revenue Next 5YN/A
EBIT growth 1Y234.11%
EBIT growth 3Y-10.35%
EBIT growth 5YN/A
EBIT Next Year262.49%
EBIT Next 3Y72.38%
EBIT Next 5YN/A
FCF growth 1Y-426.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y104.75%
OCF growth 3Y-11.42%
OCF growth 5YN/A

BKV CORPORATION / BKV Fundamental Analysis FAQ

What is the fundamental rating for BKV stock?

ChartMill assigns a fundamental rating of 4 / 10 to BKV.


What is the valuation status of BKV CORPORATION (BKV) stock?

ChartMill assigns a valuation rating of 4 / 10 to BKV CORPORATION (BKV). This can be considered as Fairly Valued.


Can you provide the profitability details for BKV CORPORATION?

BKV CORPORATION (BKV) has a profitability rating of 4 / 10.


How financially healthy is BKV CORPORATION?

The financial health rating of BKV CORPORATION (BKV) is 4 / 10.